Related Experiment Video
Updated: Jul 12, 2026

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Apneic preterms and methylxanthines: arousal deficits, sleep fragmentation and suppressed spontaneous movements
M J Hayes1, M R Akilesh, M Fukumizu
1Graduate School of Biomedical Sciences, University of Maine, Orono, ME, USA. Mhayes@maine.edu
Insights
Chronic methylxanthine treatment in preterm infants with apnea may cause sleep deprivation. This is due to the stimulant effects of methylxanthines on arousal and motor activity, leading to reduced sleep quality.
Area of Science:
- Neonatal Medicine
- Sleep Science
- Pharmacology
Background:
- Preterm infants with apnea are often treated with methylxanthines.
- The potential for methylxanthines to disrupt sleep patterns in this vulnerable population requires investigation.
Purpose of the Study:
- To investigate whether methylxanthine treatment in apneic preterm infants leads to sleep deprivation.
- To examine the cumulative effects of methylxanthines on arousal and motor activity during sleep.
Main Methods:
- Sleep, wake, arousal, and actigraphic movements were monitored in 37 extubated, clinically stable premature infants.
- Infants were grouped based on methylxanthine exposure: caffeine (>5 days), theophylline (>5 days), or no prior exposure.
- Participants were medication-free for over 72 hours prior to monitoring.
Main Results:
- Methylxanthine treatment duration correlated with increased arousals, wakefulness, and actigraphic movements, alongside decreased active sleep.
- Methylxanthine-exposed groups exhibited reduced waking state, fewer wake epochs, fewer brief arousals, and a lower composite arousal index.
- Sleep-related motility, including fast-burst movements, was shorter in methylxanthine-treated infants compared to controls.
Conclusions:
- Chronic methylxanthine treatment in apneic preterm infants is associated with sleep deprivation.
- The stimulatory effects of methylxanthines on arousal and motor systems appear to be the underlying mechanism for sleep disruption.
Objective:
To determine if apneic preterm infants currently treated with methylxanthines develop evidence of sleep deprivation from cumulative arousal and motor activational effects.
Study Design:
Sleep, wake, arousal and actigraphic movements were monitored in extubated clinically stable premature infants (N=37). Neonates were free of other medications for >72 h and were grouped based on methylxanthine exposure: >5 days with caffeine (n=14), >5 days theophylline (n=13) or no prior exposure (n=10).
Result:
Duration of methylxanthine treatment predicted increased arousals, wakefulness and actigraphic movements, and decreased active sleep. Recording from 1200 to 0500 hours, methylxanthine-treated groups showed reductions in all arousal parameters: waking state, number of wake epochs, brief arousals and composite arousal index, and shorter fast-burst, sleep-related motility than untreated controls.
Conclusion:
In apneic preterms, chronic methylxanthine treatment appears to produce sleep deprivation secondary to the stimulatory action of methylxanthines on arousal and motor systems.
More Related Videos
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Narcolepsy
Sleep Apnea
The condition is more prevalent among...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...